What’s stopping doctors repurposing generic medicines?

Answer – not a lot!

HELPING Dr TESS LAWRIE

This is based on an article I wrote last year while helping Dr Tess Lawrie with her company EbMCsquared CiC. The aim was to potentially license ivermectin (IVM) in the UK.

There was so much negative press on IVM at the time, that it became impossible to progress, although a reputable source, working to GMP, had been found and was willing to work with us.

NOT A LOT OF PEOPLE KNOW THIS

It begins with something not many people know:

For decades, it has been assumed only pharmaceutical companies have the wherewithal to develop or repurpose medicines. This article challenges that assumption based on changing business models in the industry.

These changes have created a skills-base of qualified contractors and contract organisations able to offer everything required to bring a medicine to market. The message to doctors, other health professionals and healthcare systems (herein referred to as doctors) is that there is just one gap in their armoury — knowledge of the supply…